摘要
胰高血糖素样肽-1(glucagon-like peptide-1,GLP-1)是一种肠促胰岛素激素,具有很好的综合降糖效果,但其在血浆中的半衰期只有短暂几分钟,限制了GLP-1在临床方面的应用.为延长GLP-1的半衰期,合成了GLP-1-Fc融合基因,将N-糖基化作用的受体天冬酰胺突变为丙氨酸,构建了无糖基化修饰的GLP-1-Fc(N126A)融合表达载体,利用酵母表达系统成功表达了GLP-1-Fc(N126A)融合蛋白,并利用r Protein A获得了高纯度融合蛋白.
Glucagon-like peptide-1(GLP-1) is a kind of ducdenin, which has good and comprehensive hypoglycemic effect. The GLP-1 was easy to be degraded in plasma. To prolong the half-life of GLP-1, the GLP-1-Fc(N126A) was constructed through mutant N-glycosylation asparagine receptor into alanine. The GLP-1-Fc(N126A) fusion protein was obtained by yest expression system, and was purified by rPro-teinA.
作者
乔晓芳
王春艳
顾宝华
田庆南
QIAO Xiaofang WANG Chunyan GU Baohua TIAN Qingnan(Department of Pharmacy, Zhengzhou University, Zhengzhou 450001, China Center of Anyang High- Tech Zone Food and Drug Administration, Anyang 455000, China School of Life Science, Zhengzhou University, Zhengzhou 450001, China)
出处
《郑州大学学报(理学版)》
CAS
北大核心
2016年第4期86-89,共4页
Journal of Zhengzhou University:Natural Science Edition
基金
国家自然科学基金青年科学基金资助项目(31601867)
中国博士后基金特别资助项目(2016T90674)